Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Roche Holding AG Structure Therapeutics Inc Novo Nordisk A/S
From CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags Compute Health Acquisition Corp Mondelez International Inc Kraft Heinz Co
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Business News Johnson & Johnson Novo Nordisk A/S
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Cigna Corp Moderna Inc Abbott Laboratories
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Biogen Inc Health care industry Pfizer Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Novo Nordisk A/S US STEEL DRN Nike Inc
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Weight management Companies Amgen Inc
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Breaking news Companies Health care industry
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags US: News Eli Lilly and Co Business
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Breaking News: Economy Economy U/S/ Economy
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Mad Money Investment strategy Tyson Foods Inc
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags US: News Eli Lilly and Co Science
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Companies Weight management Pfizer Inc
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Companies Breaking news Health care industry
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Investment Strategy U/S/ Markets Markets
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Home Depot Inc Macy's Inc
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Science Social issues Health & Science
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Investment strategy Markets Mad Money
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags Gogo Inc Investing S&P 500
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Breaking News: Business Business News Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Breaking news Companies Social issues
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Companies Breaking news Pfizer Inc
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags US: News Biotechnology Business
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Business Biotechnology Health & Science
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Health care industry Seagen Inc Pfizer Inc
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Health care industry Dexcom Inc Technology
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Markets Alphabet Inc Europe Markets
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.